Loading provider…
Loading provider…
Neurology Physician in Boston, MA
NPI: 1407977473Primary Practice Location
MASSACHUSETTS GENERAL HOSPITAL
55 Fruit St, Boston, MA
Primary Employer
Massachusetts General Physicians Organization Inc
massgeneral.org
HQ Phone
Get MD PHD Jorg's Phone Numberphone_androidMobile
Get MD PHD Jorg's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
MA State Medical License
2008 - 2025

American Board of Psychiatry and Neurology
Neurology
Rochester General Hospital
Residency • Internal Medicine
2004 - 2005
University of Giessen Faculty of Medicine
Medical School
Until 1996
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 88 | 146 |
| 2 | 99223Initial hospital inpatient care, typically 70 minutes per day | 28 | 28 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 27 | 60 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 21 | 22 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 21 | 34 |
Pegylated liposomal doxorubicin‐efficacy in patients with recurrent high‐grade glioma
Authors: Peter Hau, Klaus Fabel, Ulrike Baumgart, Petra Rümmele, Oliver Grauer, Annekatrin Bock, Christopher Dietmaier, Wolfgang Dietmaier, Jörg Dietrich, Christine Dudel, Franz Hübner, R N Tanya Jauch, Elisabeth Drechsel, Ingo Kleiter, Cäcile Wismeth, Anton Zellner, Alexander Brawanski, Andreas Steinbrecher, Jörg Marienhagen, Ulrich Bogdahn
Publication Date: 2004-03
Lead Sponsor: Dana-Farber Cancer Institute
Intervention / Treatment: DRUG: Ponatinib
Lead Sponsor: Massachusetts General Hospital
Collaborators: Eli Lilly and Company, Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center
Intervention / Treatment: DRUG: pemetrexed